Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis

American Journal of Gastroenterology

Volumn 106, Issue 11, 2011, Pages 2001-2008

  Roblin, Xavier ^a,b   Pillet, Sylvie ^a,b   Oussalah, Abderrahim ^c   Berthelot, Philippe ^a   Del Tedesco, Emilie ^b   Phelip, Jean Marc ^b   Chambonnière, Marie Laure ^b   Garraud, Olivier ^a   Peyrin Biroulet, Laurent ^c   Pozzetto, Bruno ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; VALGANCICLOVIR; VIRUS ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; SEX RATIO; SIGMOIDOSCOPY; STEROID THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS; VIRUS LOAD;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG RESISTANCE; FEMALE; GANCICLOVIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; VIRAL LOAD;

EID: 80655127784     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.202     Document Type: Article

References (35)

1. Staras SA, Dollard SC, Radford KW et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43: 1143-51. (Pubitemid 44632796)
2. Lawlor G, Moss AC. Cytomegalovirus in infl ammatory bowel disease: pathogen or innocent bystander? Infl amm Bowel Dis 2010; 16: 1620-7.
3. Hommes DW, Sterringa G, van Deventer SJ et al. Th e pathogenicity of cytomegalovirus in infl ammatory bowel disease: a systematic review and evidence-based recommendations for future research. Infl amm Bowel Dis 2004; 10: 245-50. (Pubitemid 38618254)
4. Alcala MJ, Casellas F, Pallares J et al. [Infection by cytomegalovirus in patients with ulcerative colitis requiring colonic resection]. Med Clin (Barc) 2000; 114: 201-4. (Pubitemid 30140981)
5. Cooper HS, Raff ensperger EC, Jonas L et al. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology 1977; 72: 1253-6. (Pubitemid 8116693)
6. Domenech E, Vega R, Ojanguren I et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Infl amm Bowel Dis 2008; 14: 1373-9.
7. Cottone M, Pietrosi G, Martorana G et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96: 773-5. (Pubitemid 32240729)
8. Yoshino T, Nakase H, Ueno S et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Infl amm Bowel Dis 2007; 13: 1516-21.
9. Papadakis KA, Tung JK, Binder SW et al. Outcome of cytomegalovirus infections in patients with infl ammatory bowel disease. Am J Gastroenterol 2001; 96: 2137-42. (Pubitemid 32660910)
10. Criscuoli V, Casa A, Orlando A et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36: 818-20. (Pubitemid 41070580)
11. Dimitroulia E, Spanakis N, Konstantinidou AE et al. Frequent detection of cytomegalovirus in the intestine of patients with infl ammatory bowel disease. Infl amm Bowel Dis 2006; 12: 879-84. (Pubitemid 44352715)
12. D ' Ovidio V, Vernia P, Gentile G et al. Cytomegalovirus infection in infl ammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008; 43: 180-3.
13. Kojima T, Watanabe T, Hata K et al. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol 2006; 41: 706-11. (Pubitemid 43995013)
14. Leveque N, Brixi-Benmansour H, Reig T et al. Low frequency of cytomegalovirus infection during exacerbations of infl ammatory bowel diseases. J Med Virol 2010; 82: 1694-700.
15. Matsuoka K, Iwao Y, Mori T et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007; 102: 331-7. (Pubitemid 46160547)
16. Minami M, Ohta M, Ohkura T et al. Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol 2007; 13: 754-60.
17. Takahashi Y, Tange T. Prevalence of cytomegalovirus infection in infl ammatory bowel disease patients. Dis Colon Rectum 2004; 47: 722-6. (Pubitemid 38585777)
18. Wakefi eld AJ, Fox JD, Sawyerr AM et al. Detection of herpes virus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992; 38: 183-90.
19. Kishore J, Ghoshal U, Ghoshal UC et al. Infection with cytomegalovirus in patients with infl ammatory bowel disease: prevalence, clinical signifi cance and outcome. J Med Microbiol 2004; 53: 1155-60. (Pubitemid 40052501)
20. Kandiel A, Lashner B. Cytomegalovirus colitis complicating infl ammatory bowel disease. Am J Gastroenterol 2006; 101: 2857-65. (Pubitemid 44902661)
21. Rahier JF, Ben-Horin S, Chowers Y et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in infl ammatory bowel disease. J Crohn's Colitis 2009; 3: 47-91.
22. Kou T, Nakase H, Tamaki H et al. Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis. Dig Dis Sci 2006; 51: 1052-5. (Pubitemid 44127052)
23. Stange EF, Travis SP, Vermeire S et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: defi nitions and diagnosis. J Crohn's Colitis 2008; 2: 1-23. (Pubitemid 351179487)
24. Dewit O, Starkel P, Roblin X. Th iopurine metabolism monitoring: implications in infl ammatory bowel diseases. Eur J Clin Invest 2010; 40: 1037-47.
25. Pillet S, Bourlet T, Pozzetto B. Comparative evaluation of a commercially available automated system for extraction of viral DNA from whole blood: application to monitoring of Epstein-Barr virus and cytomegalovirus load. J Clin Microbiol 2009; 47: 3753-5.
26. Fiel M, Qin L, Suriawinita a A e t al. Histologic grading of disease activity in chronic IBD: inter-and intra-observer variation among pathologists with diff erent levels of experience. Mod Pathol 2003; 16: 118A.
27. Schanen C, Nasri D, Bourlet T e t al. Enterovirus in arteriosclerosis: a pilot study. J Clin Virol 2007; 39: 106-12. (Pubitemid 46777434)
28. Travis SP, Stange EF, Lemann M et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohn's Colitis 2008; 2: 24-62. (Pubitemid 351179488)
29. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
30. Kaufman HS, Kahn AC, Iacobuzio-Donahue C et al. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999; 42: 24-30. (Pubitemid 29053116)
31. Kim CH, Bahng S, Kang KJ et al. Cytomegalovirus colitis in patients without infl ammatory bowel disease: a single center study. Scand J Gastroenterol 2010; 45: 1295-301.
32. Knosel T, Schewe C, Petersen N et al. Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract 2009; 205: 223-30.
33. Suzuki H, Kato J, Kuriyama M et al. Specifi c endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010; 16: 1245-51.
34. Nakase H, Chiba T. TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in infl amed mucosa of colon in patients with ulcerative colitis: lesson from clinical. Infl amm Bowel Dis 2010; 16: 550-1.
35. Shih DQ, Targan SR. Immunopathogenesis of infl ammatory bowel disease. World J Gastroenterol 2008; 14: 390-400. (Pubitemid 351320847)